RCM Operations: Denials & Appeals
Objective. Read denial categories and the appeal queue to prioritise by recoverable value, keeping denied/billed value distinct from what will actually be collected.
Denials and Appeals breaks the denial load into categories and surfaces the appeal queue so a leader can work the cohorts that protect the most recoverable value first. It answers 'which denials, appealed this week, protect the most cash.'
See it in the demo
What this screen answers
This screen answers the queue-choice question: with finite appeal writers, which denial category or cohort do we appeal first to protect the most recoverable value before deadlines close? A Sales person uses it to show outcome-led prioritisation instead of a flat denial report; a CSM uses it to agree which denial reasons an owner works on a standing cadence and to tie each cohort to an appeal window.
The task
Scope to the client and payer set, then read denials by category and by recoverable value and appeal eligibility together - not by raw count. Pick the cohort that concentrates recoverable value against a closing window, drill to the underlying claims as evidence, and assign an owner and review period. Frame the expected result as a hypothesis ('appealing this cohort protects this much recoverable value'), not a committed collection. Stay at the level the app supports - category, eligibility, value, window, owner.
How to read it
The classic misread is reading a denial dollar figure as recoverable cash. A denied amount is billed or at-risk value; only a share is appeal-eligible, and only a share of that will be overturned and collected. Keep the chain explicit: denied value, recoverable value (appeal-eligible and winnable), collected cash (after the appeal succeeds). 'Appeal-eligible' is not 'will be won', and 'will be won' is not 'collected'. Prioritise by recoverable value and deadline, and never let a headline denial total be quoted as money the customer will get back.
Honest limits
This screen proves the app categorises denials and surfaces an appeal queue on seeded data with drill-down to claims. It does not prove win rates, nor that the denial definitions and appeal-eligibility logic match the customer's payers. Confirm denial definitions, eligibility rules, win-rate assumptions and scope with product before quoting recoverable figures as the customer's. Recovery is the customer's validated result after the appeals are worked.
Interpretation check
A denied dollar figure is billed or at-risk value, not recoverable cash - only a share is appeal-eligible and only a share of that is won and collected. Keep denied, recoverable and collected value distinct and prioritise by recoverable value against the appeal window.
In the field
KnackGlobal (RCM): working high-value, deadline-bound denial cohorts first - and reporting recoverable separately from collected - is the honest prioritisation that differentiates against incumbent tooling showing denial volume without outcome sequencing.
Practical task
On the demo Denials and Appeals view, choose one payer or category and write a prioritisation note: the cohort you would appeal first and why (recoverable value against window), the owner, and a three-line chain labelling denied value vs recoverable value vs collected cash for that cohort.
Self-check
The screen shows $800k in denials for one payer. Is that the recovery opportunity?
No - that is denied/at-risk value. The recovery opportunity is the appeal-eligible, winnable share, and collected cash is only what is overturned and paid. Quoting the $800k as recoverable overstates it.
Should the largest denial category by count always be appealed first?
No - prioritise by recoverable value and closing appeal window together. A smaller category of high-value, deadline-bound, winnable denials can protect more cash than a large low-value one.
What is the honest way to frame the expected result of appealing a cohort?
As an outcome hypothesis - 'appealing this cohort protects this much recoverable value' - not a committed collection. Cash is the customer's validated result after the appeals succeed.
What must a CSM validate before trusting the queue for a customer?
The denial definitions, appeal-eligibility rules, any win-rate assumptions, and the payer/client scope - confirmed with product - so the prioritisation reflects the customer's real payers.
Verified vs demo. Screen is live in the demo at /#/denials; the denial categorisation, appeal queue and claim drill-down are demo-shown on seeded data, and exact controls, eligibility logic and figures are SME-validation-pending. Live denial definitions, win-rate assumptions and scope are production-dependent - confirm with product.